论文部分内容阅读
DIC并不是一个疾病的名称,而是以某些疾病为背景的一个征候群。由形成纤维蛋白类血栓、消耗特定的血清蛋白、血小板减少、纤溶系统亢进而组成。由此可推定在循环血流中存在有凝血酶。临床表现以广泛的出血及较少见的血栓形成而发病、包括低纤维蛋白血症,大出血及凝血功能检查异常为特征的后天出血性疾病,但这一征候群的病因只能以纤溶亢进作为结论而已。因后天性出血及血栓性疾病所引起的临床症状,都提示发生DIC,而使其诊断及疗效判定标准不明确。目前对凝血酶元时间延长、血小板减少、
DIC is not the name of a disease, but a syndrome that is based on certain diseases. By the formation of fibrin thrombus, consumption of specific serum protein, thrombocytopenia, fibrinolytic system and composition. From this it can be inferred that thrombin is present in the circulating blood stream. Clinical manifestations are extensive hemorrhage and rare thrombosis and disease, including hypofibrinogenemia, bleeding and coagulation abnormalities characterized by acquired haemorrhagic disease, but the symptoms of this syndrome can only fibrinolysis As a conclusion only. Due to acquired hemorrhage and thrombotic disease caused by clinical symptoms, have prompted the occurrence of DIC, leaving its diagnostic and efficacy criteria are not clear. Currently on the prothrombin time, thrombocytopenia,